<DOC>
	<DOCNO>NCT00548210</DOCNO>
	<brief_summary>The purpose research demonstrate effectivity Dermatix promote maturation scar , versus control region treat indifferent cream .</brief_summary>
	<brief_title>Effectivity Dermatix Promoting Scar Maturation</brief_title>
	<detailed_description>The heal deep thermal injury always associate scarring . The heal process lead formation large scar bundle ( e.g . hypertrophic scar ) . The scar discomforting , disfigure restrict motion situate near joint . Evidence effectivity treatment reduction hypertrophic scar prevention limit . Different treatment use intralesional injected steroid , topically use oily cream , silicone sheet occlusive dressing . Compression garment also frequently use . There evidence effectivity silicone sheet recuction hypertrophic scarring , however , sheet use easily anatomical location . Valeant Pharmaceuticals International develop silicone base scar remodelling gel , DermatixÂ® , empirically show others potential reduce hypertrophic scar . Primary objective demonstrate effectivity Dermatix promote maturation scar , versus control region treat indifferent cream .</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cicatrix , Hypertrophic</mesh_term>
	<criteria>1 . Patients hypertrophic scar and/or rope , stable least 3 month inclusion . 2 . Written inform consent 3 . Scar size enable definition two distinct scar area , similar scar characteristic inclusion , preferably symmetric scar . 4 . Patients 18 year old Exclusion criterion : 1 . Known sensitivity occlusive dressing silicone contain product 2 . Any patient condition may influence compliance treatment negatively .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Hypertrophy</keyword>
	<keyword>scar</keyword>
	<keyword>scar treatment</keyword>
	<keyword>silicone</keyword>
</DOC>